Real-time enrollment status for this epithelioid hemangioendothelioma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:20 PM UTC
| NCT Number | NCT07104331 |
| Recruiting Status | Recruiting |
| Condition | Epithelioid Hemangioendothelioma |
| Phase | PHASE2 |
| Target Enrollment | 41 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Sarcoma Alliance for Research through Collaboration |
| Last Updated on CT.gov | May 26, 2026 (May 26, 2026) |
As of August 27, 2026: Clinical trial NCT07104331 is currently recruiting participants. This phase2 study for epithelioid hemangioendothelioma is actively seeking new participants at 6 locations across the United States. The study is sponsored by Sarcoma Alliance for Research through Collaboration. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07104331 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07104331 was last updated May 26, 2026 (May 26, 2026). HelloStudys verifies this status automatically.